GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KDR, KIT, MMP2, MMP9, POLB, PPARA, PTGS2, SRC, TERT, TOP1, TYR |
10.5678 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KDR, KIT, MMP2, POLB, PPARA, PTGS2, SRC, TYR |
9.76201 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP3, GSK3B, HSD17B2, IDO1, IGF1R, MMP2, MMP9, POLB, PPARA, PTGS2, SRC, TYR |
9.76201 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
9.68928 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, KIT, MET, PPARA, PTGS2, TBXAS1 |
9.49194 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSD17B2, KDR, KIT, MET, POLA1, POLB, PPARA, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
8.75797 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIM1, POLA1, POLB, PPARA, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
8.21816 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
8.18973 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FUT7, IDO1, PIM1, PPARA, PTGS2, TBXAS1, TYR, XDH |
8.18973 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
8.18763 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
8.02278 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, GSK3B, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
7.86236 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, GSK3B, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
7.84695 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
7.58582 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD17B1, HSD17B2, IDO1, PTGS2, TBXAS1, TYR, XDH |
7.55589 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
7.35582 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DYRK1A, FABP4, FLT3, FUT7, GSK3B, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PIM1, POLB, PPARA, PTGS2, PTPRS, SRC, TERT, TNKS2, TYR |
7.35582 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, FABP3, FLT3, GSK3B, IGF1R, KIT, MMP2, PPARA, PTGS2, SRC |
6.92206 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KDR, KIT, MMP2, MMP9, POLA1, POLB, PPARA, PTGS2, SRC, TERT, TOP1, TYR |
6.54101 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, PTGS2, TERT |
6.52128 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, MMP9, PTGS2, SRC, TERT |
6.39928 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TERT |
6.3132 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, PIM1, SRC |
6.3132 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, IDO1, PTGS2, SRC, TYR |
6.30262 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, F10, FLT3, GSK3B, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
6.30262 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
6.28448 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, KIT, MET, PPARA, PTGS2, TBXAS1 |
6.28448 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
6.16249 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, SRC, TERT |
6.10251 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DYRK1A, FLT3, GSK3B, HSD17B2, KDR, KIT, MMP9, PIM1, POLB, PPARA, PTGS2, PTPRS, SRC, TYR |
6.05495 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
6.04226 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9, DHFR |
6.04226 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, MMP9, POLA1, POLB, PTGS2, SRC, TERT |
6.03168 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2, TBXAS1 |
5.88972 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DHFR, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, POLB, PTGS2, PTPRS, SRC, TNKS, TOP1, XDH |
5.82999 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, BCL2, CSNK2A1, CYP1B1, DNMT1, FABP3, FLT3, IDO1, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
5.81772 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TERT, XDH |
5.80353 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, F10, FABP4, FLT3, GSK3B, IDO1, KDR, KIT, MET, MMP2, MMP9, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
5.69166 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, PTGS2, SRC |
5.66768 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
5.64924 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, F10, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP9, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
5.64924 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.60786 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
5.60786 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2 |
5.594 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, F10, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP9, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
5.55551 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, PTGS2, SRC, TYR |
5.55551 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DHFR, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, POLB, PTGS2, PTPRS, SRC, TNKS, TOP1, XDH |
5.55551 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
5.46558 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
5.24347 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
5.22399 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TERT |
5.19517 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, KIT, POLB, PPARA, PTPRS, SRC, TYR |
5.15576 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DYRK1A, F10, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP2, MMP9, PPARA, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
5.08003 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, F10, FABP3, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
5.04463 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS, TOP1 |
5.03391 |
[BP] GO:0019371 |
None
|
AKR1C3, CBR1, PTGS2, TBXAS1 |
5.00016 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, IDO1, PPARA, PTGS2, TBXAS1 |
4.98148 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.96634 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, F10, FABP4, HSD17B2, IDO1, IGF1R, KIT, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TNKS2, TOP1, TYR |
4.94055 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CYP1B1, F10, FLT3, KDR, KIT, MET, PTGS2, SRC, XDH |
4.8427 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
4.82502 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, SRC, TERT |
4.78587 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TBXAS1, TYR |
4.76485 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DHFR, FABP3, KDR, POLB, PTGS2, SRC, TOP1 |
4.75677 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DHFR, DNMT1, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
4.71882 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DHFR, TYR |
4.71698 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, F10, FLT3, GSK3B, IGF1R, KDR, KIT, MET, SRC, TNKS, TOP1 |
4.66733 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.58946 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.57554 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, F10, FLT3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, XDH |
4.57517 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, MMP1, MMP2, MMP9, SRC, XDH |
4.52892 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.52658 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TERT, TNKS |
4.51786 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
4.51367 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GSK3B, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
4.50842 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.5048 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.49817 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.46035 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.35667 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TBXAS1, TYR |
4.30584 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.24821 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TBXAS1, TYR |
4.22049 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, GSK3B, KIT, PPARA, SRC, TOP1 |
4.22049 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, POLB, PPARA, PTGS2, SRC, TERT |
4.13565 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, DHFR, DYRK1A, F10, FLT3, FUT7, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, POLB, PPARA, PTGS2, PTPRS, SRC, TNKS, TNKS2, TOP1, TYR, XDH |
4.11681 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.11576 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, IDO1, KIT, MMP2, MMP9, POLA1, POLB, PPARA, PTGS2, SRC, TERT |
4.0583 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DHFR, DYRK1A, FABP4, GSK3B, IDO1, IGF1R, MET, MMP2, PPARA, PTGS2, PTPRS, SRC, TERT, XDH |
4.04011 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
4.04011 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, KIT, MMP2, POLB, PPARA, PTGS2, SRC, TERT, TYR |
4.0385 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS, TOP1 |
4.02638 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
3.99862 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DNMT1, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
3.9394 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, DNMT1, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
3.87933 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, GSK3B, IGF1R, KDR, KIT, MET, MMP9, PPARA, PTGS2, SRC, TERT |
3.82746 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, FLT3, KIT, MET, PIM1, POLA1, SRC, TYR |
3.76327 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DYRK1A, GSK3B, SRC, TNKS, TOP1 |
3.76327 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, KIT, MMP9, TERT |
3.76327 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.76327 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, F10, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP9, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
3.75426 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
3.65992 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
3.65891 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, MMP9, SRC |
3.63545 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, MMP9, PTGS2, SRC |
3.63292 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2 |
3.6105 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
3.57785 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, DNMT1, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
3.57602 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DHFR, PPARA |
3.57602 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
3.57239 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.56986 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.56986 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.56986 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DYRK1A, GSK3B, SRC, TNKS, TOP1 |
3.51489 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
3.49243 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CYP1A1, FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
3.47728 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
3.4653 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, KDR, PTGS2, SRC, TNKS, TNKS2 |
3.43151 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.41874 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
3.40824 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, IDO1 |
3.40078 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, FABP4, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TNKS |
3.35343 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, GSK3B, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
3.28477 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.28477 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.28477 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, BCL2, CSNK2A1, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, PTGS2, TERT |
3.27861 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, DNMT1, GSK3B, IGF1R, MMP2, MMP9, PTGS2, SRC |
3.24036 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, FABP3, FABP4, FLT3, MET, POLA1, POLB, SRC, TERT |
3.23134 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
3.21586 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
3.21586 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, F10, KIT, MET, SRC, XDH |
3.17809 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, DYRK1A, GSK3B, TNKS |
3.17716 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.17716 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, KDR, POLB, SRC |
3.17716 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, KIT, PTGS2 |
3.17716 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, KIT, PTGS2 |
3.17716 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, BCL2, CA2, FLT3, PTGS2, SRC |
3.09048 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, IDO1 |
3.08778 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, KIT, PTGS2 |
3.0572 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.05362 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, DYRK1A, GSK3B, TNKS |
3.01138 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.96048 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, F10, KIT, MET, SRC |
2.94406 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, PTGS2 |
2.92711 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, DNMT1, FLT3, GSK3B, IGF1R, KIT, MMP2, PTGS2, SRC |
2.91858 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.91858 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.91858 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.91858 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.91858 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, FLT3, PTGS2, SRC |
2.91483 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX15, ALOX5, CYP19A1, CYP1A1, DHFR, IDO1, PTGS2 |
2.91208 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.89771 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AURKB, BCL2, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP9, PPARA, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
2.84696 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CYP19A1, DHFR, TYR |
2.81936 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.79882 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, IGF1R, PPARA, PTGS2, SRC |
2.76496 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, POLB, TYR |
2.75157 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APP, CYP1A1, CYP1B1, FLT3, PTGS2, SRC |
2.75157 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, BCL2, CYP1B1, DHFR, PTGS2, XDH |
2.72626 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.72086 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AKR1C3, ALOX15, AXL, BCL2, CA2, CA9, CYP1B1, DHFR, GSK3B, MMP9, POLA1, POLB, PTGS2, SRC, TERT |
2.69585 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A1, HSD17B2, IDO1, KIT, MMP2, MMP9, PTGS2, SRC |
2.67967 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.64631 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, XDH |
2.60477 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.58898 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, BCL2, CYP19A1, HSD17B2, KIT, SRC |
2.57933 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.57933 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.57933 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.57933 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
2.52294 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.51996 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.51567 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.51033 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.51033 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.48538 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, DYRK1A, F10, FLT3, FUT7, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIM1, POLB, PTPRS, SRC, TNKS, TNKS2, TOP1 |
2.4853 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
2.476 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
2.43974 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, GSK3B, IGF1R, MMP2, PTGS2, SRC |
2.43974 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, TERT, TNKS, TNKS2 |
2.42499 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, DYRK1A, F10, FLT3, FUT7, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, POLB, PPARA, PTPRS, SRC, TNKS, TNKS2, TOP1 |
2.42499 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, DYRK1A, GSK3B, IGF1R, MET, PTGS2, PTPRS, TERT, XDH |
2.42499 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.4101 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.4101 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.40327 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AXL, BCL2, CBR1, CYP1A1, FABP4, FLT3, FUT7, GSK3B, KDR, KIT, MET, MMP2, MMP9, PTGS2, PTPRS, SRC, TERT |
2.38753 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.38466 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.37832 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.36073 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, GSK3B, PTGS2, SRC, TERT |
2.34188 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.3321 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.3321 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2 |
2.31741 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.31497 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.31394 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.31009 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CYP19A1, DYRK1A, GSK3B, IGF1R, MET, MMP9, PPARA, PTGS2, PTPRS, SRC, TERT, XDH |
2.30134 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM2, KIT, PTGS2 |
2.29567 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.29565 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.29482 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AURKB, BCL2, DNMT1, DYRK1A, FABP3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP9, PPARA, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
2.27458 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.27299 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.27299 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27299 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, IGF1R, SRC, TNKS, TNKS2 |
2.26882 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, GSK3B, IGF1R, MMP2, PTGS2, SRC |
2.24993 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCL2, CYP1A1, PTGS2, SRC, TYR |
2.22342 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, BCL2, CYP1B1, FABP3, IDO1, PTGS2, TERT, XDH |
2.18801 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, DHFR, FLT3 |
2.18801 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.1783 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.14566 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, PTGS2, TNKS, TNKS2 |
2.14042 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.13658 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.13658 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CYP1A1, POLB, PTGS2, TERT |
2.09652 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.09044 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, SRC, TNKS, TNKS2 |
2.09044 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APP, AURKB, BCL2, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP4, GSK3B, IGF1R, KDR, MET, MMP9, PPARA, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
2.09023 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.09023 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.09023 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP9, PPARA, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
2.09023 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, DNMT1, DYRK1A, FLT3, KDR, KIT, MMP9, PTGS2, SRC, XDH |
2.08946 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.0647 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.0629 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.04265 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AXL, BCL2, CYP19A1, HSD17B2, KIT, PTGS2, SRC |
2.03116 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.02934 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.02934 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.02934 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.02892 |
[BP] GO:0070542 |
None
|
AKR1C3, FABP3, PTGS2, SRC |
2.00923 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AURKB, BACE1, BCL2, CA2, CA4, CA7, CBR1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, KDR, KIT, MMP2, MMP9, PIM1, POLA1, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.70001 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FLT3, FUT7, GSK3B, HSD17B2, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TYR |
2.38327 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA2, CA4, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, GSK3B, IDO1, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
2.13644 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, F10, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPRS, SRC, TERT |
2.09023 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, GSK3B, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
2.09023 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AURKB, AXL, BACE1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, F10, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
16.3393 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DNMT1, DYRK1A, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
11.4751 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, MMP1, MMP2, MMP9, PIM1, PPARA, TBXAS1, TNKS, TYR, XDH |
8.73136 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
8.18763 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD17B1, HSD17B2, IDO1, PTGS2, TBXAS1, TYR, XDH |
7.97325 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9, POLB |
5.68821 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC, TBXAS1 |
5.52115 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, PPARA, SRC, TOP1 |
5.51025 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC, TBXAS1 |
5.28696 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, F10, IDO1, KIT, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, TBXAS1, TERT, TNKS, TNKS2, TYR, XDH |
5.27562 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.12698 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
5.12698 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1, TYR |
4.98096 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, F10, IDO1, KIT, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGS2, TBXAS1, TERT, TNKS, TNKS2, TYR, XDH |
4.97675 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD17B1, IDO1, POLA1, PTGS2, SRC, TBXAS1, XDH |
4.96634 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
4.90351 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.88382 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, POLA1, POLB, SRC, TERT, TOP1 |
4.67006 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.56303 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1 |
4.52892 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.36171 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD17B1, HSD17B2, XDH |
4.25304 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AURKB, AXL, CSNK2A1, DHFR, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, POLA1, SRC, TOP1, TUBB3, XDH |
3.82926 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.82705 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1 |
3.7571 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.63777 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.63777 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DHFR, DYRK1A, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, PTPRS, SRC, TOP1, TUBB3, XDH |
3.61205 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.58569 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9, POLB |
3.51489 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD17B1, HSD17B2 |
3.47728 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP1 |
3.41159 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DHFR, DNMT1, DYRK1A, FLT3, GSK3B, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, POLA1, SRC, TOP1, TUBB3, XDH |
3.17809 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DHFR, DNMT1, DYRK1A, FLT3, GSK3B, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, POLA1, SRC, TOP1, TUBB3, XDH |
3.17759 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.91858 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, XDH |
2.85969 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.82492 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, IDO1, XDH |
2.57933 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.51033 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.51033 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ADORA1, APP, AURKB, AXL, CSNK2A1, DYRK1A, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, POLA1, PTPRS, SRC, TOP1, TUBB3 |
2.50951 |
[MF] GO:0016740 |
transferase activity
|
AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, FUT7, GSK3B, IGF1R, KDR, KIT, MET, PIM1, POLA1, POLB, SRC, TERT, TNKS, TNKS2, TOP1 |
2.37629 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, CA9, DNMT1, MMP1, MMP2, MMP9, PPARA, TNKS |
2.34188 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.1783 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2 |
2.13658 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, CSNK2A1, DYRK1A, F10, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPRS, SRC, TOP1 |
2.09044 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2 |
2.0647 |